Roberto Crea

CREAGRI, Inc. develops and supplies antioxidant polyphenols. Its products are used for functional foods, health and dietary supplements. The company was founded by Roberto Crea in 1998 and is headquartered in Hayward, CA.

Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA.

Part of Pfizer Inc., Bioren LLC is a company that develops human antibodies for medical uses. The company is based in San Carlos, CA. The company was founded by Roberto Crea. Bioren was acquired by Pfizer Inc. on August 15, 2005.

Creative Biomolecules, Inc. develops products for human tissue regeneration and organs based on morphogenic proteins. The company was founded by Roberto Crea, Fred Bernard Craves and Charles Cohen and is headquartered in Hopkinton, MA.

Part of Perrigo Co. Plc, Creagen, Inc. is a biopharmaceutical development company. The company is based in Cambridge, MA. The company was founded by André L. Lamotte, Roberto Crea. Creagen was acquired by Neurex Corp. on July 26, 1994 for $8.05 million.

City of Hope is a research and treatment center for cancer, diabetes and various life-threatening diseases. The center is founded in 1913 and is headquartered in Los Angeles, CA.

Agroils Technologies SpA develops industrial process for the production of biofuel animal feed and molecules. It focuses on processes enabling the production of biofuels, animal feed and molecules of pharmaceutical interest from no-food Jatropha energy crop. The company's technology is a process which does not make use of fossil alcohols, which makes it cheaper and environmental friendly. Agroils Technologies was founded by Roberto Crea and Giovanni Venturini del Greco in 2011 and it is headquartered in Sesto Fiorentino, Italy.

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.